Zhitong Finance App News, Jinyao Pharmaceutical (600488.SH) issued an announcement. Recently, the company's subsidiary Jinyao Heping (Tianjin) Pharmaceutical Co., Ltd. (hereinafter referred to as “Jinyao Heping”) pediatric compound amino acid injection (18AA-I) received a drug registration certificate from the Ministry of Health of Myanmar (indicating that the product can be produced and sold in the Myanmar market). This product has successfully obtained overseas listing qualifications, building a solid foundation for the company's pharmaceutical sector to develop overseas markets, opening up new business growth space, and will also strongly promote the steady implementation of the international development strategy.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.